Skip to main content

Abstract

Relapse rates appear to be relatively high in the period of time following the cessation of an acute course of rTMS treatment. A number of strategies can be explored to minimise relapse rates. These include the provision of appropriate ongoing antidepressant medication, possibly combined with a mood stabiliser such as lithium. Specific forms of psychotherapy are also likely to have relapse prevention potential although these have not been systematically evaluated following rTMS treatment. A number of methods for the provision of rTMS maintenance have been proposed, although only limited data has explored the efficacy of these to date. Patients who have responded well to rTMS treatment and subsequently relapsed appear to have a high likelihood of responding to a subsequent course of rTMS treatment with no accumulation of risks or side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Grunhaus L, Dolberg O, Lustig M (1995) Relapse and recurrence following a course of ECT: reasons for concern and strategies for further investigation. J Psychiatr Res 29(3):165–172, Epub 1995/05/01

    Article  PubMed  CAS  Google Scholar 

  2. Tew JD Jr, Mulsant BH, Haskett RF, Joan P, Begley AE, Sackeim HA (2007) Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. Ann Clin Psychiatry 19(1):1–4, Epub 2007/04/25

    Article  PubMed  Google Scholar 

  3. Dannon PN, Dolberg OT, Schreiber S, Grunhaus L (2002) Three and six-month outcome ­following courses of either ECT or rTMS in a population of severely depressed individuals – preliminary report. Biol Psychiatry 51(8):687–690

    Article  PubMed  Google Scholar 

  4. Cohen RB, Boggio PS, Fregni F (2009) Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression. Depress Anxiety 26(7):682–688

    Article  PubMed  Google Scholar 

  5. Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM et al (2010) Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul 3(4):187–199, Epub 2010/10/23

    Article  PubMed  Google Scholar 

  6. Robinson RG, Tenev V, Jorge RE (2009) Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression. Am J Geriatr Psychiatry 17(8):682–687

    Article  PubMed  Google Scholar 

  7. Dell’osso B, D’Urso N, Castellano F, Ciabatti M, Altamura AC (2011) Long-term efficacy after acute augmentative repetitive transcranial magnetic stimulation in bipolar depression: a 1-year follow-up study. J ECT 27(2):141–144, Epub 2010/10/23

    Article  PubMed  Google Scholar 

  8. van den Broek WW, Birkenhager TK, Mulder PG, Bruijn JA, Moleman P (2006) Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial. J Clin Psychiatry 67(2):263–268, Epub 2006/03/29

    Article  PubMed  Google Scholar 

  9. Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM et al (2001) Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 285(10):1299–1307, Epub 2001/03/20

    Article  PubMed  CAS  Google Scholar 

  10. Rehor G, Conca A, Schlotter W, Vonthein R, Bork S, Bode R et al (2009) Relapse rate within 6 months after successful ECT: a naturalistic prospective peer- and self-assessment analysis. Neuropsychiatr 23(3):157–163, Epub 2009/08/26. Ruckfallraten innerhalb von 6 Monaten nach erfolgreicher EKT-Eine naturalistische prospektive Fremd- und Selbstbeurteilungsanalyse

    PubMed  CAS  Google Scholar 

  11. Gloaguen V, Cottraux J, Cucherat M, Blackburn IM (1998) A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord 49(1):59–72, Epub 1998/05/09

    Article  PubMed  CAS  Google Scholar 

  12. Blackburn IM, Eunson KM, Bishop S (1986) A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. J Affect Disord 10(1):67–75, Epub 1986/01/01

    Article  PubMed  CAS  Google Scholar 

  13. Evans MD, Hollon SD, DeRubeis RJ, Piasecki JM, Grove WM, Garvey MJ et al (1992) Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 49(10):802–808, Epub 1992/10/01

    Article  PubMed  CAS  Google Scholar 

  14. Simons AD, Murphy GE, Levine JL, Wetzel RD (1986) Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year. Arch Gen Psychiatry 43(1):43–48, Epub 1986/01/01

    Article  PubMed  CAS  Google Scholar 

  15. Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S (2004) Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry 161(10):1872–1876, Epub 2004/10/07

    Article  PubMed  Google Scholar 

  16. Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R et al (1999) Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry 56(9):829–835, Epub 2003/07/30

    Article  PubMed  CAS  Google Scholar 

  17. Paykel ES, Scott J, Cornwall PL, Abbott R, Crane C, Pope M et al (2005) Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial. Psychol Med 35(1):59–68, Epub 2005/04/22

    Article  PubMed  CAS  Google Scholar 

  18. Beck J (1996) Cognitive therapy: basics and beyond. Guilford Press, New York

    Google Scholar 

  19. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA (2000) Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 68(4):615–623, Epub 2000/08/31

    Article  PubMed  CAS  Google Scholar 

  20. Ma SH, Teasdale JD (2004) Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol 72(1):31–40, Epub 2004/02/06

    Article  PubMed  Google Scholar 

  21. Chiesa A, Serretti A (2011) Mindfulness based cognitive therapy for psychiatric disorders: a systematic review and meta-analysis. Psychiatry Res 187(3):441–453, Epub 2010/09/18

    Article  PubMed  Google Scholar 

  22. Kuyken W, Byford S, Taylor RS, Watkins E, Holden E, White K et al (2008) Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. J Consult Clin Psychol 76(6):966–978, Epub 2008/12/03

    Article  PubMed  Google Scholar 

  23. Kuyken W, Watkins E, Holden E, White K, Taylor RS, Byford S et al (2010) How does mindfulness-based cognitive therapy work? Behav Res Ther 48(11):1105–1112, Epub 2010/09/03

    Article  PubMed  Google Scholar 

  24. Fenton L, Fasula M, Ostroff R, Sanacora G (2006) Can cognitive behavioral therapy reduce relapse rates of depression after ECT? A preliminary study. J ECT 22(3):196–198, Epub 2006/09/08

    Article  PubMed  Google Scholar 

  25. Isserles M, Rosenberg O, Dannon P, Levkovitz Y, Kotler M, Deutsch F et al (2011) Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome. J Affect Disord 128(3):235–242, Epub 2010/07/29

    Article  PubMed  Google Scholar 

  26. O’Reardon JP, Blumner KH, Peshek AD, Pradilla RR, Pimiento PC (2005) Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 66(12):1524–1528

    Article  PubMed  Google Scholar 

  27. Li X, Nahas Z, Anderson B, Kozel FA, George MS (2004) Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression? Depress Anxiety 20(2):98–100

    Article  PubMed  CAS  Google Scholar 

  28. Demirtas-Tatlidede A, Mechanic-Hamilton D, Press DZ, Pearlman C, Stern WM, Thall M et al (2008) An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients. J Clin Psychiatry 69(6):930–934

    Article  PubMed  Google Scholar 

  29. Fitzgerald PB, Benitez J, de Castella AR, Brown TL, Daskalakis ZJ, Kulkarni J (2006) Naturalistic study of the use of transcranial magnetic stimulation in the treatment of depressive relapse. Aust N Z J Psychiatry 40(9):764–768, Epub 2006/08/17

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fitzgerald, P.B., Daskalakis, Z.J. (2013). Maintenance and Continuation Treatment. In: Repetitive Transcranial Magnetic Stimulation Treatment for Depressive Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-36467-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-36467-9_9

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-36466-2

  • Online ISBN: 978-3-642-36467-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics